Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Women's Choice Aesthetics & Mammography in Trumbull, CT Expands Menu to Include One of the Fastest and Most Effective Non-Invasive Fat Reduction Treatments on the Market

Women's Choice Aesthetics & Mammography is now offering truSculpt® iD, the only non-invasive fat reduction treatment on the market that has been clinically proven to reduce up to 24 percent of targeted fat cells in one 15-minute treatment.


News provided by

Women’s Choice Aesthetics & Mammography

Oct 26, 2018, 22:00 ET

Share this article

Share toX

Share this article

Share toX

TRUMBULL, Conn., Oct. 26, 2018 /PRNewswire-PRWeb/ -- Women's Choice Aesthetics & Mammography is proud to add a leading non-invasive fat reduction treatment truSculpt® iD to its menu of results-driven aesthetic and wellness treatments. truSculpt iD has been clinically proven to reduce up to 24 percent of targeted fat cells, on average, in one 15-minute treatment.

truSculpt® iD uses non-invasive radiofrequency (RF) energy to heat targeted fat deposits on almost any area of the body, including the abdomen, flanks, thighs, arms, back, bra roll and chin. Once fat cells undergo lipolysis (fat breakdown), they are naturally flushed from the body in the months following treatment. One treatment is typically recommended; results can be seen within 6-8 weeks, with continued improvement up to 12 weeks.

truSculpt's RF energy targets and disables fat cells through 6 comfortable, hand-held paddles, which rest on the targeted areas during treatment. Fully-customizable, these paddles can be placed on numerous areas of the body simultaneously, treating broader areas, as necessary, or multiple areas at once.

Unlike other non-invasive fat reduction treatments, truSculpt is a comfortable and efficient treatment. Patients liken truSculpt to a hot stone massage which lasts only 15 minutes per treatment.

To learn more about truSculpt iD or schedule a consultation, visit Women's Choice Aesthetics & Mammography or call 203.445.0101 today.

About Drs. Evangeline Specht and Neil Specht 
Heading the aesthetic branch of Women's Choice Aesthetics & Mammography, Medical Director Dr. Evangeline S. Specht is a board-certified Internist who has been practicing medicine for more than 25 years. She branched into aesthetic medicine after joining her husband at Women's Choice Aesthetics & Mammography several years ago. Passionate about bringing you the best, Dr. Evangeline Specht strives to provide the highest level of results-driven, clinically-backed treatments for significant improvements with minimal downtime. "Our treatment goal is to give our clients a natural and healthy appearance to their skin—not a frozen one!" says Dr. Specht. "If every one of our patients can look at their faces in the mirror and say, 'I know the answer to 'who's the fairest one of all?' then we have done our job!"

Medical Director of Mammography Dr. Neil T. Specht is dual board-certified in Internal Medicine & Radiology. He served as the Chief of Ultrasound and Interventional Radiology at St. Vincent's Medical Center until 2010, when he opened his independent imaging center, Connecticut Ultrasound & Biopsy Center. He opened Women's Choice Mammography in 2011, and expanded to Women's Choice Aesthetics & Mammography in 2014. He operates this practice with his wife, Dr. Evangeline Specht.

Dr. Neil Specht serves as an instructor at the largest medical convention in the world and is internationally recognized in the field of interventional ultrasound. He has performed more than 25,000 biopsies during his career. Having perfected his Gentle-Touch™ technique, Dr. Neil Specht's procedures are virtually pain-free and scar-free.

About Women's Choice Aesthetics & Mammography 
Women's Choice Aesthetics & Mammography offers leading, results-driven aesthetic treatments to help women look and feel their best, in addition to receiving the highest level of mammography testing. Women's Choice Aesthetics & Mammography offers a wide range of treatments including HydraFacial®, laser hair removal, Botox®/Dysport® and dermal fillers, radio-frequency skin tightening, platelet-rich plasma (PRP) skin rejuvenation, PRP hair restoration, radio-frequency micro-needling, skin rejuvenation using Laser Genesis and PICO Genesis™, laser tattoo removal, stretch mark treatment, non-surgical body contouring, vein treatments, skin care products, acne treatments, and more.

Women's Choice Aesthetics & Mammography was the first 3-D mammography center in Fairfield County and offers this superior technology to every patient. Dr. Neil Specht and his staff provide unparalleled personalized care in a warm, relaxed environment. He meets with patients to discuss their exam results before they leave the office. "Patients deserve the best technology and a higher level of service than what they are accustomed to, and that is what we provide."

SOURCE Women’s Choice Aesthetics & Mammography

Related Links

https://womenschoicect.com/index.html

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.